MLUAX
Price
$12.95
Change
-$0.08 (-0.61%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

MLUAX vs VMVAX

Header iconMLUAX vs VMVAX Comparison
Open Charts MLUAX vs VMVAXBanner chart's image
MassMutual Mid Cap Value A
Price$12.95
Change-$0.08 (-0.61%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MLUAX vs VMVAX Comparison Chart
Loading...
VS
MLUAX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLUAX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. MLUAX (55.2M). VMVAX pays higher dividends than MLUAX: VMVAX (2.14) vs MLUAX (0.92). MLUAX was incepted earlier than VMVAX: MLUAX (18 years) vs VMVAX (13 years). MLUAX is a more actively managed with annual turnover of: 79.00 vs. VMVAX (22.00). MLUAX has a lower initial minimum investment than VMVAX: MLUAX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. MLUAX (20.54). VMVAX return over 5 years is better than : 48.82 vs. MLUAX (9.70).
MLUAXVMVAXMLUAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years13 years-
Gain YTD11.46314.94677%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets55.2M30.5B0%
Annual Yield % from dividends0.922.1443%
Returns for 1 year20.5425.3581%
Returns for 3 years-10.7420.71-52%
Returns for 5 years9.7048.8220%
Returns for 10 years-7.10100.88-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio